GH Research

News

After setbacks with psychedelics, phase 2b data with GH Research's GH001 for treatment-resistant depression could lift confidence in the category.

News

Having already committed last year to capital investments of $27 billion in the US to ward off the threat of tariffs, Eli Lilly has upped the ante.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.